February 16,2006
Senator Grassley's Statement for the Record regarding FDA's Approval Process
Please see the following two documents attached as related files:
(1) Grassley Statement from the Feb. 16 Congressional Record
(2) Report of the Committee Staff Review of the FDA’s Approval Process for the Vagus Nerve Stimulation Therapy System for Treatment-Resistant Depression
Next Article Previous Article
Recent News
- Crapo: Tax Relief Gives Phenomenal Boost to Working Americans
- Historic Tax Filing Season Brings Larger Refunds to More People, More Quickly
- Crapo Announces Hearing on the President’s Trade Agenda
- Senate Republicans: Working Families Tax Cuts are Delivering Real Results for Americans
- Crapo Announces Hearing on 2027 HHS Budget